Novartis's Secret Settlement Talks Revealed in Accidental Filing
- U.S. says ‘significant progress’ made toward suit resolution
- Trial scheduled to start May 20 was indefinitely delayed
A logo sits on display on a building at the Novartis AG campus in Basel, Switzerland.
Photographer: Stefan Wermuth/BloombergThis article is for subscribers only.
Confidential settlement talks between Novartis AG and the U.S. government over allegations that the company paid doctors to market its products are not so secret anymore.
The U.S. sued the Swiss drugmaker six years ago, joining in a case filed by a former sales representative who accused the company of using its speakers programs to pay kickbacks to doctors who prescribed its drugs. The case was scheduled to go to trial before U.S. District Judge Paul Gardephe in Manhattan on May 20 when it was delayed indefinitely without a reason.